|
Ordering Steps:
|
1
|
2
|
3
|
4
|
5
|
6
|
|
|
Choose Journal
|
Choose Article
|
Provide/ Confirm Article Details
|
Checkout
|
Payment
|
Confirmation
|
Select the article title from the table below. You can shorten the results table
by clicking on the alphabet menu or using the search function.
If the article that you wish to purchase is not listed below, please click on
"Select An Article Not Listed Above" to proceed.
|
Paper No.
|
Article Title
|
First Author
|
Vol No./ Issue No.
|
|
12873
|
Sarcopenia predicts minimal hepatic encephalopathy in patients with liver cirrhosis
|
T. Hanai
|
Vol 47 (No. 13 To 13)
|
|
12874
|
Clinical results of proton beam therapy for hepatocellular carcinoma over 5 cm
|
K. Kimura
|
Vol 47 (No. 13 To 13)
|
|
12875
|
Immunoserological and histological differences between autoimmune hepatitis with acute presentation and chronic autoimmune hepatitis
|
K. Dohmen
|
Vol 47 (No. 13 To 13)
|
|
12876
|
Liver tissue metabolic profiling and pathways of non-alcoholic steatohepatitis in rats
|
S. Qi
|
Vol 47 (No. 13 To 13)
|
|
12877
|
Identification of core gene networks and hub genes associated with progression of non-alcoholic fatty liver disease by RNA sequencing
|
K. Hotta
|
Vol 47 (No. 13 To 13)
|
|
12878
|
25-Hydroxy vitamin D suppresses hepatitis C virus replication and contributes to rapid virological response of treatment efficacy
|
J.-F. Huang
|
Vol 47 (No. 13 To 13)
|
|
12880
|
Excretion of necrotic hepatocellular carcinoma tissues into the biliary system after transcatheter arterial chemoembolization
|
S. Miyayama
|
Vol 47 (No. 13 To 13)
|
|
12882
|
“ Reversi-type virologic failure ” involved in the development of non-structural protein 5A resistance-associated variants (RAVs) in patients with genotype 1b hepatitis C carrying no signature RAVs at baseline
|
Y. Uchida
|
Vol 47 (No. 13 To 13)
|
|
12883
|
Hepatic nucleotide binding oligomerization domain - like receptors pyrin domaincontaining 3 inflammasomes are associated with the histologic severity of non-alcoholic fatty liver disease
|
H. Mitsuyoshi
|
Vol 47 (No. 13 To 13)
|
|
12884
|
VAP score as a novel non-invasive liver fibrosis model in patients with chronic hepatitis C
|
E. Ahmed Hassan
|
Vol 47 (No. 13 To 13)
|
|
12885
|
Non-alcoholic fatty liver disease phosphoproteomics: A functional piece of the precision puzzle
|
J. Wattacheril
|
Vol 47 (No. 13 To 13)
|
|
12887
|
Ezetimibe for the treatment of non-alcoholic fatty liver disease: A meta-analysis
|
Y. Nakade
|
Vol 47 (No. 13 To 13)
|
|
12888
|
Diabetes mellitus not an unfavorable factor on the prognosis of hepatitis C virus-related hepatocellular carcinoma
|
N. Yoshida
|
Vol 48 (No. 1 To 1)
|
|
12889
|
Efficacy of sofosbuvir and ledipasvir therapy in patients co-infected with hepatitis C virus genotypes 1 and 2
|
T. Sohda
|
Vol 47 (No. 13 To 13)
|
|
12890
|
Impact of hepatitis C virus recombinant form RF1_2k/1b on treatment outcomes within the Georgian national hepatitis C elimination program
|
M. Karchava
|
Vol 48 (No. 1 To 1)
|